Martin Whyte, an associate professor of metabolic medicine at the University of Surrey, explains one possible theory as to why people tend to regain weight after they stop these medications
MASLD Metabolic dysfunction-associated steatotic liver disease - excess fat in the liver linked to metabolic health
Professional advice, great for international patient
In this study, with a median follow-up of 25 months, the primary composite end point including cardiovascular death, MI, stroke, and hospitalization for unstable angina occurred in 406 patients (13.4%) in the lixisenatide group and in 399 (13.2%) in the placebo group (HR, 1.02
Akinola O, Gabriel M, Suleiman A-A, Olorunsogbon F
Keep Injecting